A multicenter study on the clinical efficacy and safety of roxithromycin in the treatment of ear-nose-throat infections: Comparison with amoxycillin/clavulanic acid

Journal of Chemotherapy

Volumn 13, Issue 6, 2001, Pages 621-627

  Mira, E ^a   Benazzo, M ^a   Bigoni, A ^a   Franzetti, A ^a   Ciolli, A ^a   Scheiber, E ^a   Ponzi, S ^a   Schipano, M ^a   Pintucci, J P ^a   Castellani, C ^a   Brusa, M ^a   Bini, A ^a   Rognoni, S ^a   Canepa, A ^a   Gamoletti, R ^a   De Fronzo, C ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Amoxycillin clavulanic acid; Ear nose throat infections; Roxithromycin; Upper respiratory tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ROXITHROMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EAR NOSE THROAT DISEASE; ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOACUSIS; MALE; MULTICENTER STUDY; NAUSEA; OTALGIA; OTITIS MEDIA; OTOSCOPY; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; STOMACH PAIN; TABLET; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 0035691122     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.6.621     Document Type: Article

References (16)

1. Problemi clinici delle infezioni batteriche delle prime vie respiratorie
2. Roxithromycin. A macrolide with improved pharmacokinetic properties
3. Antimicrobial activity, pharmacokinetics and clinical use of roxithromycin. An overview
4. Roxithromycin in the therapy of Streptococcus pyogenes throat infections
5. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
6. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use
7. Multicentre study of the efficacy and tolerability of roxithromycin in the treatment of respiratory tract infections
8. Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections
9. Studio comparativo sull'efficacia e la tollerabilità di roxitromicina vs amoxicillina/acido clavulanico nelle patologie infettive otorinolaringoiatriche. Studio multicentrico
10. Profilo farmacocinetico della roxitromicina alla posologia di 300 mg in dose unica giornaliera
11. Nationwide survey in Italy of treatment of Streptococco pyogenes pharyngitis in children: Influence of macrolide resistance on clinical and microbiological outcomes: Artemys-Italy Study Group
12. Macrolide antibiotics as antiinflammatory agents: Roxithromycin in an unexpected role
13. Modulation of cytokine production from human mononuclear cells by several agents
14. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin
15. Somministrazione di roxitromicina in unica dose giornaliera: Esperienza clinica italiana
16. Clinical evidence of roxithromycin 300 mg once daily as an alternative to 150 mg twice daily